Steroid-resistant idiopathic esophageal ulcer in a child with AIDS

Journal of Pediatric Gastroenterology and Nutrition

Volumn 27, Issue 1, 1998, Pages 97-101

  Jibaly, Rima M ^a   Moallem, Hamid ^a   Fikrig, Senih M ^a   Rabinowitz, Simon S ^a  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CIMETIDINE; FLUCONAZOLE; HYDROCORTISONE SODIUM SUCCINATE; PREDNISONE; RANITIDINE; STEROID; SUCRALFATE; THALIDOMIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANDIDIASIS; CASE REPORT; DRUG RESISTANCE; ESOPHAGUS ULCER; FEMALE; HERPES VIRUS INFECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; PRIORITY JOURNAL; STEROID THERAPY; ULCER HEALING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; CANDIDIASIS; CHILD, PRESCHOOL; DRUG RESISTANCE; ESOPHAGEAL DISEASES; FEMALE; HUMANS; HYDROCORTISONE; PREDNISONE; RECURRENCE; STEROIDS; THALIDOMIDE; ULCER;

EID: 0031813824     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005176-199807000-00018     Document Type: Article

References (23)

1. Wilcox CM, Schwanz DA, Clark WS. Esophageal ulceration in human immunodeficiency virus infection. Ann Int Med 1995;123:143-9.
2. Sor S, Levine MS, Kowalski TE, Laufer I, Rubesin SE, Herlinger H. Giant ulcers of the esophagus in patients with human immunodeficiency virus: Clinical, radiographic and pathologic findings. Radiology 1995;194:447-51.
3. Martinez EJ, Nord JH, Cooper BG. Significance of solitary and multiple esophageal ulcers in patients with AIDS. South Med J 1995;88:626-9.
4. Kotler DP, Reka S, Orenstein JM, Fox CH. Chronic idiopathic esophageal ulceration in the acquired immunodeficiency syndrome, characterization and treatment with corticosteriods. J Clin Gastroenterol 1992;15:284-90.
5. Wilcox CM, Straub RF, Schwartz DA. Prospective endoscopic characterization of cytomegalovirus esophagitis in AIDS. Gastrointest Endosc 1994;40:481-4.
6. Kitchen VS, Helbert M, Francis ND, et al. Epstein-Barr virus associated esophageal ulcers in AIDS. Gut 1990;31:1223-5.
7. Bonacini M, Young T, Laine L. The causes of esophageal symptoms in human immunodeficiency virus infection. Arch Intern Med 1991;151:1567-72.
8. Chow D, Bleikh S, Eickhoff L, Soloway G, Saul Z. Primary esophageal lymphoma in AIDS presenting as a nonhealing esophageal ulcer. Am J Gastroenterol 1996;91:602-3.
9. Wilcox CM, Schwanz DA. Comparison of two corticosteroid regimens for the treatment of HIV-associated idiopathic esophageal ulcer. Am J Gastmenterol 1994;89:2163-7.
10. 1994 revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR 1994; 43:1-19.
11. Wilcox CM, Schwanz, DA. Endoscopic characterization of idiopathic esophageal ulceration association with human immunodeficiency virus infection. J Clin Gastroenterol 1993;16:251-6.
12. Clarke LM, McPhee JM, Cummings RV. Isolation of viruses in conventional tube culture: Selection and inoculation of cell cultures. In: Isenberg HD, ed. Clinical microbiology procedures handbook. Vol. 2, Sec. 8.5.1-13). American Society for Microbiology: Washington, DC, 1992.
13. Kotler DP, Wilson CS, Haroutiounian G, Fox CH. Detection of human immunodeficiency virus by 35 S-RNA in situ hybridization in solitary esophageal ulcers in two patients with the acquired immune deficiency syndrome. Am J Gastroenterol 1989;84:313-7.
14. Jalfon IM, Sitton JE, Hammer RA, Agrawal NM, Ertan A, Mahatma M. HIV-1 gp41 antigen demonstration in esophageal ulcers with acquired immunodeficiency syndrome. J Clin Gastroenterol 1991;13:644-8.
15. Chawla S, Ramani K, Chawla K, LoPresti PH, Mahadevia P. Giant esophageal ulcers of AIDS: Ultrastructural study. Am J Gastroenterol 1994;89:411-5.
16. Wilcox CM, Zaki SR, Coffield LM, Greer PW, Schwartz DA. Evaluation of idiopathic esophageal ulceration for human immunodeficiency virus. Mod Pathol 1995;8:568-2.
17. Naum SM, Molloy PJ, Kania RJ, McGarr J, Van Thiel DH. Use of thalidomide in treatment and maintenance of idiopathic esophageal ulcers in HIV+ individuals. Dig Dis Sci 1995;40:1147-8.
18. Paterson DL, Georghiou PR, Allworth AM, Kemp RJ. Thalidomide as treatment of refractory aphthous ulceration related to human immunodeficiency virus infection. Clin Infect Dis 1995;20:250-4.
19. Ghigliotti G, Repetto T, Farris A, Roy M, DeMarch R. Thalidomide for severe aphthous ulceration in patients with human immunodeficiency virus (HIV) infection. J Am Acad Dermatol 1993;28:271-2.
20. Menni S, Imondi D, Brancaleone W, Croci S. Recurrent giant aphthous ulcers in a child: Protracted Treatment with thalidomide. Pediatr Dermatol 1993;10:283-5.
21. Klausner JD, Makonkawkeyoon S, Akarasewi P, et al. The effect of thalidomide on the pathogenesis of human immunodeficiency virus type 1 and M. tuberculosis infection. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:247-57.
22. Moreira AL, Sampaio EP, Zmuidzinas A, Frindt P, Smith KA, Kaplan G. Thalidomide exerts its inhibitory action on tumor necrosis factor α by enhancing mRNA degradation. J Exp Med 1993; 177:1675-80.
23. Rabeneck L, Popovic M, Gartner S, et al. Acute HIV infection presenting with painful swallowing and esophageal ulcers. JAMA 1990;263:2318-22.